PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I , University of Bonn , An der Immenburg 4 , D-53121 Bonn , Germany.
College of Pharmacy and Institute of Drug Research and Development , Chungnam National University , Daejeon 34134 , Korea.
J Med Chem. 2018 Sep 13;61(17):7395-7418. doi: 10.1021/acs.jmedchem.7b00967. Epub 2018 May 24.
Melanins are pigment molecules that determine the skin, eye, and hair color of the human subject to its amount, quality, and distribution. Melanocytes synthesize melanin and provide epidermal protection from various stimuli, such as harmful ultraviolet radiation, through the complex process called melanogenesis. However, serious dermatological problems occur when there is excessive production of melanin in different parts of the human body. These include freckles, melasma, senile lentigo, pigmented acne scars, and cancer. Therefore, controlling the production of melanin is an important approach for the treatment of pigmentation related disorderes. In this Perspective, we focus on the inhibitors of melanogenesis that directly/indirectly target a key enzyme tyrosinase as well as its associated signaling pathways.
黑色素是决定人类皮肤、眼睛和头发颜色的色素分子,其数量、质量和分布决定了颜色。黑色素细胞合成黑色素,并通过称为黑色素生成的复杂过程为表皮提供对各种刺激(如有害的紫外线辐射)的保护。然而,当人体不同部位黑色素生成过多时,会出现严重的皮肤问题。这些问题包括雀斑、黄褐斑、老年斑、色素性痤疮疤痕和癌症。因此,控制黑色素的生成是治疗色素沉着相关疾病的重要方法。在本观点中,我们重点介绍了直接/间接靶向关键酶酪氨酸酶及其相关信号通路的黑色素生成抑制剂。